{
    "Trade/Device Name(s)": [
        "CCPoint",
        "EuroDiagnostica CCPoint"
    ],
    "Submitter Information": "Euro-Diagnostica AB",
    "510(k) Number": "K093908",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052133"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NHX"
    ],
    "Summary Letter Date": "December 1, 2010",
    "Summary Letter Received Date": "November 22, 2010",
    "Submission Date": "November 19, 2010",
    "Regulation Number(s)": [
        "21 CFR 866.5775"
    ],
    "Regulation Name(s)": [
        "Rheumatoid factor immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "IgG antibodies to Cyclic Citrullinated Peptides (CCP)",
        "Anti-CCP"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Rapid lateral flow immunoassay",
        "Colloidal gold-based lateral flow",
        "Qualitative visually read assay"
    ],
    "Methodologies": [
        "Lateral flow immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Euro-Diagnostica CCPoint visually read lateral flow test to detect IgG anti-CCP antibodies in human serum or plasma for rheumatoid arthritis diagnosis",
    "Indications for Use Summary": "Qualitative rapid lateral flow test for detection of IgG antibodies to CCP in human plasma or serum, aiding the diagnosis of rheumatoid arthritis in conjunction with other clinical findings and laboratory results, for trained laboratory professionals, for in vitro diagnostic use",
    "fda_folder": "Immunology"
}